Latest Insider Transactions at Morphic Holding, Inc. (MORF)
This section provides a real-time view of insider transactions for Morphic Holding, Inc. (MORF). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Morphic Holding, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Morphic Holding, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 09
2020
|
Praveen P. Tipirneni President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,508
+30.21%
|
$10,032
$4.32 P/Share
|
Nov 06
2020
|
Praveen P. Tipirneni President and CEO |
SELL
Open market or private sale
|
Indirect |
4,331
-0.66%
|
$112,606
$26.13 P/Share
|
Nov 06
2020
|
Praveen P. Tipirneni President and CEO |
SELL
Open market or private sale
|
Direct |
4,367
-57.06%
|
$113,542
$26.14 P/Share
|
Nov 06
2020
|
Praveen P. Tipirneni President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,367
+36.33%
|
$17,468
$4.32 P/Share
|
Nov 05
2020
|
Praveen P. Tipirneni President and CEO |
SELL
Open market or private sale
|
Indirect |
6,525
-0.99%
|
$169,650
$26.85 P/Share
|
Nov 05
2020
|
Praveen P. Tipirneni President and CEO |
SELL
Open market or private sale
|
Direct |
6,643
-66.91%
|
$172,718
$26.85 P/Share
|
Nov 05
2020
|
Praveen P. Tipirneni President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,643
+40.09%
|
$26,572
$4.32 P/Share
|
Nov 04
2020
|
Praveen P. Tipirneni President and CEO |
SELL
Open market or private sale
|
Indirect |
6,238
-0.94%
|
$162,188
$26.58 P/Share
|
Nov 04
2020
|
Praveen P. Tipirneni President and CEO |
SELL
Open market or private sale
|
Direct |
6,100
-64.99%
|
$158,600
$26.58 P/Share
|
Nov 04
2020
|
Praveen P. Tipirneni President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,100
+39.39%
|
$24,400
$4.32 P/Share
|
Nov 03
2020
|
Praveen P. Tipirneni President and CEO |
SELL
Open market or private sale
|
Indirect |
2,575
-0.19%
|
$66,950
$26.18 P/Share
|
Nov 03
2020
|
Praveen P. Tipirneni President and CEO |
SELL
Open market or private sale
|
Direct |
2,605
-25.23%
|
$67,730
$26.06 P/Share
|
Nov 03
2020
|
Praveen P. Tipirneni President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,605
+30.66%
|
$10,420
$4.32 P/Share
|
Nov 02
2020
|
Praveen P. Tipirneni President and CEO |
SELL
Open market or private sale
|
Indirect |
7,736
-0.57%
|
$193,400
$25.87 P/Share
|
Nov 02
2020
|
Praveen P. Tipirneni President and CEO |
SELL
Open market or private sale
|
Direct |
7,777
-41.98%
|
$194,425
$25.86 P/Share
|
Nov 02
2020
|
Praveen P. Tipirneni President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,777
+41.28%
|
$31,108
$4.32 P/Share
|
Oct 26
2020
|
Robert E Farrell Jr SVP Finance and CAO |
SELL
Open market or private sale
|
Direct |
1,760
-1.59%
|
$49,280
$28.74 P/Share
|
Oct 26
2020
|
Alexey Lugovskoy Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,367
-0.74%
|
$38,276
$28.78 P/Share
|
Oct 23
2020
|
Robert E Farrell Jr SVP Finance and CAO |
SELL
Open market or private sale
|
Direct |
2,300
-3.98%
|
$64,400
$28.31 P/Share
|
Oct 23
2020
|
Alexey Lugovskoy Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,318
-2.44%
|
$64,904
$28.31 P/Share
|
Oct 19
2020
|
Robert E Farrell Jr SVP Finance and CAO |
SELL
Open market or private sale
|
Direct |
100
-0.17%
|
$2,800
$28.05 P/Share
|
Oct 19
2020
|
Alexey Lugovskoy Chief Development Officer |
SELL
Open market or private sale
|
Direct |
100
-0.11%
|
$2,800
$28.22 P/Share
|
Oct 12
2020
|
Robert E Farrell Jr SVP Finance and CAO |
SELL
Open market or private sale
|
Direct |
1,149
-1.94%
|
$31,023
$27.02 P/Share
|
Oct 12
2020
|
Alexey Lugovskoy Chief Development Officer |
SELL
Open market or private sale
|
Direct |
718
-0.75%
|
$19,386
$27.03 P/Share
|
Oct 09
2020
|
Robert E Farrell Jr SVP Finance and CAO |
SELL
Open market or private sale
|
Direct |
1,916
-3.14%
|
$49,816
$26.75 P/Share
|
Oct 09
2020
|
Alexey Lugovskoy Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.03%
|
$26,000
$26.8 P/Share
|
Oct 08
2020
|
Robert E Farrell Jr SVP Finance and CAO |
SELL
Open market or private sale
|
Direct |
1,915
-3.04%
|
$49,790
$26.71 P/Share
|
Oct 08
2020
|
Alexey Lugovskoy Chief Development Officer |
SELL
Open market or private sale
|
Direct |
905
-0.46%
|
$23,530
$26.73 P/Share
|
Oct 07
2020
|
Robert E Farrell Jr SVP Finance and CAO |
SELL
Open market or private sale
|
Direct |
6,584
-4.85%
|
$171,184
$26.19 P/Share
|
Oct 07
2020
|
Alexey Lugovskoy Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,213
-1.6%
|
$83,538
$26.26 P/Share
|
Oct 06
2020
|
Robert E Farrell Jr SVP Finance and CAO |
SELL
Open market or private sale
|
Direct |
1,315
-0.93%
|
$34,190
$26.63 P/Share
|
Oct 06
2020
|
Alexey Lugovskoy Chief Development Officer |
SELL
Open market or private sale
|
Direct |
637
-0.31%
|
$16,562
$26.63 P/Share
|
Oct 05
2020
|
Robert E Farrell Jr SVP Finance and CAO |
SELL
Open market or private sale
|
Direct |
2,000
-2.75%
|
$52,000
$26.56 P/Share
|
Oct 05
2020
|
Alexey Lugovskoy Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.97%
|
$26,000
$26.5 P/Share
|
Oct 02
2020
|
Robert E Farrell Jr SVP Finance and CAO |
SELL
Open market or private sale
|
Direct |
1,842
-1.24%
|
$47,892
$26.2 P/Share
|
Oct 02
2020
|
Alexey Lugovskoy Chief Development Officer |
SELL
Open market or private sale
|
Direct |
900
-0.44%
|
$23,400
$26.25 P/Share
|
Oct 01
2020
|
Robert E Farrell Jr SVP Finance and CAO |
SELL
Open market or private sale
|
Direct |
3,279
-4.21%
|
$88,533
$27.61 P/Share
|
Oct 01
2020
|
Alexey Lugovskoy Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,627
-1.55%
|
$43,929
$27.6 P/Share
|
Jul 01
2019
|
Glaxosmithkline PLC Director |
BUY
Open market or private purchase
|
Indirect |
333,333
+11.23%
|
$4,999,995
$15.0 P/Share
|
Jul 01
2019
|
Glaxosmithkline PLC Director |
BUY
Conversion of derivative security
|
Indirect |
2,300,439
+38.26%
|
-
|
Jun 28
2019
|
Novo Holdings > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
666,667
+20.13%
|
$10,000,005
$15.0 P/Share
|
Jun 28
2019
|
Novo Holdings > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,978,779
+50.0%
|
-
|